Brief: Cyclacel Pharmaceuticals Reports Third Quarter 2022 Financial Results

Bio Green Med Solution

09/11/2022 21:14

Nov 9 (Reuters) - Cyclacel Pharmaceuticals Inc  CYCC.O :
    * CYCLACEL PHARMACEUTICALS REPORTS THIRD QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
    * CYCLACEL PHARMACEUTICALS INC- ORAL FADRACICLIB DAILY
DOSING WELL
TOLERATED IN 18 EVALUABLE PATIENTS TREATED IN DOSE-ESCALATION OF
PHASE 1/2 TRIAL
    * CYCLACEL PHARMACEUTICALS INC- EXPECT TO DETERMINE
RECOMMENDED
PHASE 2 DOSE FOR ORAL FADRACICLIB AND START PHASE 2 IN 1Q 2023
    * CYCLACEL PHARMACEUTICALS INC- CASH RUNWAY TO END OF 2023
    * CYCLACEL PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.42

Source text for Eikon:  ID:nGNX3dsNLP 
Further company coverage:  CYCC.O 
 ((Reuters.Briefs@thomsonreuters.com;))